Open AccessThe Safety of Incretin-Based Therapies—Review of the Scientific Evidence
Author(s) -
Daniel J. Drucker,
Steven I. Sherman,
Richard M. Bergenstal,
John B. Buse
Publication year - 2011
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2011-0599
Subject(s) - incretin , medicine , pancreatitis , pancreatic cancer , medullary thyroid cancer , type 2 diabetes , cancer , diabetes mellitus , pharmacology , bioinformatics , endocrinology , thyroid cancer , biology
Antidiabetic therapies based on potentiation of incretin action are now widely used; however, understanding of their long-term safety remains incomplete.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom